Development head Shannon exits as Novartis re-org continues
Novartis' head of global drug development James Shannon will leave the company as the drugmaker continues a reorganization of its pharmaceuticals division.
Your Email Address:
Recipient(s) Email Address:
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
Include a message (optional):
The e-mail address(es) that you supply to use this service will only be used to send the requested article.